0,956  0,004  Apoptosis agonist
0,941  0,005  Antiinflammatory
0,919  0,003  Nitric oxide antagonist
0,883  0,005  Antineoplastic (lung cancer)
0,862  0,003  Antineoplastic (pancreatic cancer)
0,857  0,005  Antineoplastic (breast cancer)
0,858  0,009  Transcription factor NF kappa B inhibitor
0,845  0,004  Antineoplastic (melanoma)
0,837  0,003  AR expression inhibitor
0,837  0,007  Caspase 9 stimulant
0,813  0,005  Antileukemic
0,795  0,005  Antineoplastic (ovarian cancer)
0,779  0,006  Chemopreventive
0,766  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,746  0,005  Hepatic disorders treatment
0,743  0,007  Prostate cancer treatment
0,707  0,003  Antineoplastic (endocrine cancer)
0,692  0,005  Apoptosis antagonist
0,671  0,008  Antineoplastic (cervical cancer)
0,646  0,019  Antineoplastic (colorectal cancer)
0,644  0,018  Antineoplastic (colon cancer)
0,629  0,007  Antineoplastic (glioma)
0,626  0,009  NOS2 expression inhibitor
0,620  0,004  Hepatoprotectant
0,621  0,013  Sensitization
0,627  0,023  Antidiabetic
0,627  0,023  Cyclophilin D inhibitor
0,589  0,003  Interferon gamma antagonist
0,580  0,009  Antineoplastic (multiple myeloma)
0,559  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,582  0,028  TNF expression inhibitor
0,555  0,007  Antihypoxic
0,547  0,005  ICAM1 expression inhibitor
0,531  0,004  Antiviral (Influenza A)
0,527  0,007  Antineoplastic (liver cancer)
0,540  0,021  5 Hydroxytryptamine release stimulant
0,521  0,005  Contraceptive
0,520  0,005  Protein-tyrosine phosphatase inhibitor
0,516  0,006  Prostatic (benign) hyperplasia treatment
0,532  0,022  Bone diseases treatment
0,507  0,005  Antiviral (Influenza)
0,505  0,004  Prostate disorders treatment
0,518  0,018  Caspase 3 stimulant
0,511  0,018  NOS3 expression inhibitor
0,500  0,020  Antioxidant
0,484  0,005  Antiacne
0,487  0,022  Antiosteoporotic
0,471  0,009  Diuretic
0,488  0,026  Cytotoxic
0,478  0,019  Antiprotozoal (Leishmania)
0,461  0,002  Aldosterone antagonist
0,465  0,009  Hair growth stimulant
0,475  0,022  Cardiovascular analeptic
0,452  0,019  Tumour necrosis factor alpha release inhibitor
0,444  0,021  UGT2B4 substrate
0,446  0,028  Chemoprotective
0,435  0,017  Vascular (periferal) disease treatment
0,421  0,005  Antidiabetic (type 1)
0,418  0,003  Inducible nitric-oxide synthase inhibitor
0,420  0,013  Abortion inducer
0,407  0,004  Contraceptive female
0,405  0,006  Diabetic nephropathy treatment
0,400  0,005  Gastrin inhibitor
0,396  0,004  Cholesterol synthesis inhibitor
0,417  0,035  Cardioprotectant
0,394  0,020  Transcription factor STAT3 inhibitor
0,391  0,020  Sodium/bile acid cotransporter inhibitor
0,396  0,028  Renal disease treatment
0,374  0,011  Lipocortins synthesis antagonist
0,383  0,020  Wound healing agent
0,414  0,057  Immunosuppressant
0,364  0,008  Antiviral (Hepatitis B)
0,360  0,005  Antiinfertility, female
0,361  0,008  DNA polymerase I inhibitor
0,379  0,028  Antineoplastic (renal cancer)
0,352  0,003  Transcription factor NF kappa B stimulant
0,359  0,020  Antiviral (HIV)
0,361  0,030  Transcription factor STAT inhibitor
0,389  0,059  Vasodilator, peripheral
0,349  0,022  UGT1A4 substrate
0,335  0,020  UGT2B7 substrate
0,340  0,027  Antineoplastic (bladder cancer)
0,364  0,052  Antipsoriatic
0,345  0,034  Angiogenesis stimulant
0,324  0,016  Lipid peroxidase inhibitor
0,343  0,037  Antineoplastic (glioblastoma multiforme)
0,298  0,001  Heme oxygenase stimulant
0,317  0,022  Antiviral (Herpes)
0,347  0,053  Antihypercholesterolemic
0,355  0,063  Immunostimulant
0,369  0,080  Antipruritic, allergic
0,348  0,061  Antifungal
0,294  0,009  LDLR expression enhancer
0,339  0,056  Antineoplastic (brain cancer)
0,325  0,043  Antidiabetic symptomatic
0,324  0,044  Antineoplastic (lymphoma)
0,315  0,038  Antiulcerative
0,329  0,056  Interleukin 2 agonist
0,279  0,008  Farnesoid X receptor antagonist
0,278  0,008  Retinopathy treatment
0,287  0,024  Antineoplastic (squamous cell carcinoma)
0,292  0,031  P-glycoprotein inhibitor
0,313  0,052  Antipyretic
0,319  0,062  Lipoprotein disorders treatment
0,292  0,041  Antihypertriglyceridemic
0,251  0,004  5-Alpha-reductase inhibitor
0,257  0,011  UGT2B10 substrate
0,245  0,005  Nitric-oxide synthase inhibitor
0,261  0,023  Liver fibrosis treatment
0,263  0,028  Antineoplastic (carcinoma)
0,248  0,013  Antihemorrhagic
0,264  0,030  Antipruritic, non-allergic
0,256  0,026  UGT2B15 substrate
0,233  0,004  3C-Like protease (SARS coronavirus) inhibitor
0,249  0,020  UGT2B9 substrate
0,280  0,051  Antineoplastic (lymphocytic leukemia)
0,256  0,031  Antiviral (Hepatitis)
0,346  0,122  Antiarthritic
0,263  0,045  UDP-glucuronosyltransferase substrate
0,304  0,089  Cholesterol antagonist
0,287  0,072  Hypoxia-inducible factor 1 alpha inhibitor
0,296  0,081  CYP3A4 inhibitor
0,218  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,349  0,136  Alpha-glucosidase inhibitor
0,216  0,010  Contraceptive male
0,220  0,017  Arachidonic acid antagonist
0,243  0,043  Neurotrophic factor enhancer
0,239  0,041  Insulin sensitizer
0,218  0,025  Antifungal enhancer
0,201  0,009  ABCA1 expression enhancer
0,196  0,004  Anabolic
0,221  0,032  Acute respiratory distress syndrome (ARDS) treatment
0,197  0,009  Aromatase inhibitor
0,200  0,014  Androgen antagonist
0,213  0,030  Insulin secretagoues
0,256  0,074  Hypoglycemic
0,182  0,003  RNA-directed RNA polymerase stimulant
0,284  0,109  CYP3A4 substrate
0,258  0,085  Antidiabetic (type 2)
0,181  0,009  Estrogen agonist
0,248  0,077  Proliferative diseases treatment
0,208  0,039  Phospholipase C inhibitor
0,232  0,064  Antineoplastic enhancer
0,186  0,022  Adenylate cyclase stimulant
0,262  0,099  Analeptic
0,185  0,025  Cyclooxygenase 3 inhibitor
0,222  0,063  Anesthetic general
0,249  0,093  CYP2C19 substrate
0,166  0,010  UGT2B11 substrate
0,155  0,005  Na+ K+ transporting ATPase inhibitor
0,230  0,082  Teratogen
0,275  0,127  CYP2C9 substrate
0,184  0,041  Skin whitener
0,208  0,067  UGT1A1 substrate
0,304  0,164  Alzheimer's disease treatment
0,150  0,016  Antiviral (Coronavirus)
0,150  0,016  Antiviral (SARS coronavirus)
0,216  0,083  Cardiodepressant
0,162  0,031  Endometrios treatment
0,151  0,020  CC chemokine 6 receptor antagonist
0,135  0,008  Estrogen receptor beta agonist
0,159  0,039  Pregnane X receptor agonist
0,171  0,051  Anesthetic
0,180  0,061  Toxic, respiratory center
0,148  0,030  AMP-activated protein kinase stimulant
0,266  0,149  Atherosclerosis treatment
0,130  0,016  CDC25A inhibitor
0,228  0,114  Respiratory analeptic
0,153  0,039  Growth stimulant
0,125  0,015  Glycine receptor antagonist
0,201  0,091  Embryotoxic
0,114  0,007  Estrogen receptor alpha agonist
0,116  0,010  Androgen agonist
0,267  0,161  Antibacterial
0,167  0,062  Melanin inhibitor
0,260  0,163  CYP2C19 inhibitor
0,166  0,072  UGT1A3 substrate
0,250  0,156  Antiobesity
0,131  0,037  Estrogen antagonist
0,107  0,016  Postmenopausal disorders treatment
0,135  0,045  Alcohol dehydrogenase substrate
0,125  0,037  Antineoplastic antibiotic
0,160  0,075  Interleukin 6 antagonist
0,159  0,077  Antiviral (Hepatitis C)
0,127  0,047  Choleretic
0,110  0,031  Bile acid receptor antagonist
0,093  0,013  Nitric oxide donor
0,087  0,010  Lipocortins synthesis agonist
0,222  0,145  GST M1-1 substrate
0,220  0,144  CTGF expression inhibitor
0,114  0,040  Estrogen receptor beta antagonist
0,106  0,035  Glutamate release inhibitor
0,106  0,036  Topoisomerase II alpha inhibitor
0,138  0,069  Psychosexual dysfunction treatment
0,072  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,073  0,006  Farnesoid X receptor agonist
0,078  0,012  Acetyl-CoA transferase 2 inhibitor
0,105  0,039  Ornithine decarboxylase inhibitor
0,089  0,025  Anticholelithogenic
0,124  0,062  Antitussive
0,131  0,069  Acetylcholinesterase inhibitor
0,075  0,013  Mineralocorticoid receptor antagonist
0,162  0,101  Antirickettsial
0,065  0,004  Progesterone agonist
0,174  0,115  Antialcoholic
0,142  0,083  Phospholipase A2 inhibitor
0,173  0,115  Hypolipemic
0,063  0,006  5-Alpha-reductase 1 inhibitor
0,121  0,065  Autism spectrum disorders treatment
0,073  0,019  Postcoital contraceptive
0,073  0,020  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,061  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,084  0,033  Potassium channel large-conductance Ca-activated activator
0,060  0,011  Glucocorticoid antagonist
0,172  0,123  UGT1A6 substrate
0,063  0,015  Liver X receptor agonist
0,189  0,141  Amyotrophic lateral sclerosis treatment
0,098  0,050  Paget's disease treatment
0,108  0,061  UGT2B1 substrate
0,116  0,070  Topoisomerase II inhibitor
0,070  0,025  Acetyl-CoA transferase inhibitor
0,214  0,169  Vasodilator, coronary
0,051  0,007  Cholesterol ester transfer protein antagonist
0,189  0,145  UGT1A9 substrate
0,053  0,010  Heme oxygenase inhibitor
0,095  0,052  Actinic keratosis treatment
0,050  0,007  Estrone sulfatase inhibitor
0,108  0,069  SULT1A1 substrate
0,059  0,020  Estradiol 17 beta-dehydrogenase inhibitor
0,142  0,105  Carcinogenic
0,050  0,014  p53 inhibitor
0,108  0,073  Interleukin 1b antagonist
0,137  0,102  Muscle relaxant
0,072  0,039  SULT2A1 substrate
0,110  0,076  Menstruation disorders treatment
0,067  0,034  Transcription factor AP-1 inhibitor
0,205  0,172  Antithrombotic
0,037  0,004  Corticosteroid-like
0,046  0,014  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,039  0,008  5-Alpha-reductase 2 inhibitor
0,107  0,078  Microtubule formation inhibitor
0,161  0,132  Free radical scavenger
0,099  0,071  HDL-cholesterol increasing
0,059  0,032  Pregnane X receptor antagonist
0,193  0,166  5 Hydroxytryptamine uptake stimulant
0,047  0,021  Liver X receptor alpha agonist
0,034  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,078  0,052  Estrogen receptor alpha antagonist
0,055  0,030  Diacylglycerol O-acyltransferase inhibitor
0,218  0,194  15-Lipoxygenase inhibitor
0,053  0,029  Phosphorylase inhibitor
0,205  0,182  Ca(v)3.3 blocker
0,026  0,004  Telomerase stimulant
0,049  0,030  Potassium channel Kv1.3 blocker
0,046  0,028  Parathyroid hormone antagonist
0,129  0,113  Antihelmintic (Nematodes)
0,074  0,058  Keratolytic
0,159  0,144  Vasodilator
0,121  0,106  Cholinergic
0,036  0,022  Antihyperaldosteronism
0,035  0,021  Tubulin agonist
0,166  0,152  Interleukin agonist
0,205  0,191  FMO1 substrate
0,017  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,025  0,014  Retinoid X gamma receptor agonist
0,089  0,078  Sulfotransferase substrate
0,028  0,017  Hedgehog signaling activator
0,070  0,061  Cushing's syndrome treatment
0,049  0,040  Anesthetic inhalation
0,027  0,018  Retinoid X gamma receptor antagonist
0,148  0,140  Antiparkinsonian, rigidity relieving
0,028  0,020  1,3-Beta-glucan synthase inhibitor
0,063  0,055  Premenstrual syndrome treatment
0,022  0,014  Vitamin D receptor antagonist
0,023  0,016  Retinoic acid receptor agonist
0,083  0,076  SULT1E1 substrate
0,022  0,016  Retinoic acid gamma receptor agonist
0,085  0,079  Protease inhibitor
0,015  0,009  Glucocorticoid agonist
0,020  0,014  Retinoic acid alpha receptor antagonist
0,067  0,061  Glycine receptor agonist
0,039  0,034  Hypogonadism treatment
0,135  0,130  Antihelmintic
0,060  0,056  Bcl2 antagonist
0,007  0,003  Transcortin receptor antagonist
0,031  0,028  Progesterone antagonist
0,036  0,034  Retinoic acid alpha receptor agonist
0,041  0,040  Microtubule stabilization
0,109  0,107  Protein kinase stimulant
0,131  0,130  Platelet adhesion inhibitor

